Screener/Healthcare/Biotechnology

LGND

Ligand Pharmaceuticals IncorporatedNASDAQ
$202.02+1.66 (+0.83%)
Mid CapHealthcareFastest GrowingMost Profitable
$93.58
$227.92
$195.45
$202.02
EPS (TTM)$5.89
P/E Ratio34.30
Dividend Yield—
Market Cap$4.00B
Volume124K
Prev Close$200.36
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$59.7M$44.8M$2.18—75.1%
Q3 '25$115.5M$117.3M$5.68—101.6%
Q2 '25$47.6M$4.8M$0.24—10.2%
Q1 '25$45.3M-$42.5M$-2.21—-93.6%
Q4 '24$42.8M-$31.1M$-1.68—-72.6%
Q3 '24$51.8M-$7.2M$-0.39—-13.8%
Q2 '24$41.5M-$51.9M$-2.88—-125.0%
Q1 '24$31.0M$86.1M$4.75—278.1%
Get Your Daily Market Recap